Protein arginine methyltransferase 4 modulates nitric oxide synthase uncoupling and cerebral blood flow in Alzheimer's disease
Journal of Cellular Physiology · 2024-06 · 239 (6)
DOI: 10.1002/jcp.30858 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular Physiology, online erschienen am 29.08.2022. Verfasst von Garrett A Clemons und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cellular Biology & Anatomy, Louisiana State University Health Sciences Center, Shreveport, Louisiana, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Arginine, Cerebrovascular Circulation, Mice, Transgenic. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: American Heart Association-American Stroke Association, NINDS NIH HHS.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer's disease (AD) is the leading cause of mortality, disability, and long‐term care burden in the United States, with women comprising the majority of AD diagnoses. While AD‐related dementia is associated with tau and amyloid beta accumulation, concurrent derangements in cerebral blood flow have been observed alongside these proteinopathies in humans and rodent models. The homeostatic production of nitric oxide synthases (NOS) becomes uncoupled in AD which leads to decreased NO‐mediated vasodilation and oxidative stress via the production of peroxynitrite (ONOO−∙) superoxide species. Here, we investigate the role of the novel protein arginine methyltransferase 4 (PRMT4) enzyme function and its downstream product asymmetric dimethyl arginine (ADMA) as it relates to NOS dysregulation and cerebral blood flow in AD. ADMA (type‐1 PRMT product) has been shown to bind NOS as a noncanonic ligand causing enzymatic dysfunction. Our results from RT‐qPCR and protein analyses suggest that aged (9−12 months) female mice bearing tau‐ and amyloid beta‐producing transgenic mutations (3xTg‐AD) express higher levels of PRMT4 in the hippocampus when compared to age‐ and sex‐matched C57BL6/J mice. In addition, we performed studies to quantify the expression and activity of different NOS isoforms. Furthermore, laser speckle contrast imaging analysis was indicative that 3xTg‐AD mice have dysfunctional NOS activity, resulting in reduced production of NO metabolites, enhanced production of free‐radical ONOO−, and decreased cerebral blood flow. Notably, the aforementioned phenomena can be reversed via pharmacologic PRMT4 inhibition. Together, these findings implicate the potential importance of PRMT4 signaling in the pathogenesis of Alzheimer's‐related cerebrovascular derangement.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cellular Biology & Anatomy, Louisiana State University Health Sciences Center, Shreveport, Louisiana, USA.
- Oregon Health and Science University, Portland, Oregon, USA.
- Department of Neurology, Louisiana State University Health Sciences Center, Shreveport, Louisiana, USA.
- Department of Biomedical Sciences, West Virginia School of Osteopathic Medicine, Lewisburg, West Virginia, USA.
- Center for Molecular Biology and Biotechnology, Florida Atlantic University, Jupiter, Florida, USA.
- Department of Biomedical Sciences, Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, Florida, USA.
ORCID-Profile: Shailaja Allani, Hung Wen Lin
Förderung
- American Heart Association-American Stroke Association
- NINDS NIH HHS
Zitieren
APA
Clemons, G. A., Silva, A. C. E., Acosta, C. H., Udo, M. S. B., Tesic, V., Rodgers, K. M., Wu, C. Y., Citadin, C. T., Lee, R. H., Neumann, J. T., Allani, S., Prentice, H., Zhang, Q., & Lin, H. W. (2024). Protein arginine methyltransferase 4 modulates nitric oxide synthase uncoupling and cerebral blood flow in Alzheimer's disease. Journal of Cellular Physiology, 239(6). https://doi.org/10.1002/jcp.30858
Vancouver
Clemons GA, Silva ACE, Acosta CH, Udo MSB, Tesic V, Rodgers KM, et al. Protein arginine methyltransferase 4 modulates nitric oxide synthase uncoupling and cerebral blood flow in Alzheimer's disease. Journal of Cellular Physiology. 2024;239(6). doi:10.1002/jcp.30858
BibTeX
@article{Clemons2024,
author = {Clemons, Garrett A and Silva, Alexandre Couto E and Acosta, Christina H and Udo, Mariana Sayuri Berto and Tesic, Vesna and Rodgers, Krista M and Wu, Celeste Yin-Chieh and Citadin, Cristiane T and Lee, Reggie Hui-Chao and Neumann, Jake T and Allani, Shailaja and Prentice, Howard and Zhang, Quanguang and Lin, Hung Wen},
title = {Protein arginine methyltransferase 4 modulates nitric oxide synthase uncoupling and cerebral blood flow in Alzheimer's disease},
journal = {Journal of Cellular Physiology},
year = {2024},
volume = {239},
number = {6},
doi = {10.1002/jcp.30858}
}
EUVIMED